Publisher
Deutscher Arzte-Verlag GmbH
Reference26 articles.
1. Buja LM, Roberts WC: Iron in the heart. Etiology and clinical significance. Am J Med 1971; 51: 209–21.
2. Gattermann N, Porter JB, Lopes LF, Seymour J: Consensus statement on iron overload in myelodysplastic syndromes. Hematology/Oncology Clinics of North America 2005; 19 (Suppl 1): 18–25.
3. Schafer AI, Cheron RG, Dluhy R, Cooper B, Gleason RE, Soeldner JS et al.: Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med 1981; 304: 319–24.
4. Jensen PD, Heickendorff L, Pedersen B, Bendix-Hansen K, Jensen FT, Christensen T et al.: The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload. Br J Haematol 1996; 94: 288–99.
5. di Tucci AA, Murru R, Alberti D, Rabault B, Deplano S, Angelucci E: Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade, ICL670). Eur J Haematol 2007; 78: 540–2.
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献